REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,349,009 | 0.0% | 25,836 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,349,009 | +159.7% | 25,836 | +8.5% | 0.00% | – |
| Q4 2022 | $904,466 | -99.8% | 23,808 | +6.9% | 0.00% | – |
| Q3 2022 | $559,595,000 | -43.2% | 22,268 | -31.3% | 0.00% | -100.0% |
| Q2 2022 | $985,456,000 | +4.9% | 32,427 | +13.0% | 0.00% | – |
| Q1 2022 | $939,721,000 | +36.8% | 28,685 | +10.1% | 0.00% | – |
| Q4 2021 | $686,727,000 | -78.1% | 26,042 | -16.3% | 0.00% | -100.0% |
| Q3 2021 | $3,129,475,000 | -30.8% | 31,105 | -2.7% | 0.00% | -50.0% |
| Q2 2021 | $4,522,451,000 | +19.3% | 31,954 | -16.0% | 0.00% | 0.0% |
| Q1 2021 | $3,791,391,000 | -20.1% | 38,028 | -1.0% | 0.00% | 0.0% |
| Q4 2020 | $4,747,009,000 | +48.5% | 38,400 | +17.1% | 0.00% | 0.0% |
| Q3 2020 | $3,195,669,000 | -35.9% | 32,803 | +2.6% | 0.00% | -33.3% |
| Q2 2020 | $4,987,021,000 | +47.1% | 31,964 | +36.1% | 0.00% | +50.0% |
| Q1 2020 | $3,390,113,000 | -24.6% | 23,487 | +6.8% | 0.00% | -33.3% |
| Q4 2019 | $4,494,393,000 | +185.2% | 21,985 | +12.0% | 0.00% | +200.0% |
| Q3 2019 | $1,575,692,000 | +10.9% | 19,625 | +30.3% | 0.00% | 0.0% |
| Q2 2019 | $1,421,383,000 | +60.3% | 15,065 | +45.2% | 0.00% | 0.0% |
| Q1 2019 | $886,580,000 | +80.8% | 10,373 | +18.7% | 0.00% | – |
| Q4 2018 | $490,370,000 | -31.4% | 8,741 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $714,664,000 | -80.1% | 8,741 | -95.0% | 0.00% | -66.7% |
| Q1 2018 | $3,591,220,000 | -31.1% | 175,096 | -4.8% | 0.00% | -25.0% |
| Q4 2017 | $5,210,796,000 | -10.3% | 183,997 | -1.5% | 0.00% | -20.0% |
| Q3 2017 | $5,809,169,000 | – | 186,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |